Economic evaluation of brief psychodynamic interpersonal therapy in patients with multisomatoform disorder.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 24465387.
- Also identified by DOI 10.1371/journal.pone.0083894 and PMC identifier 3898909.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
A brief psychodynamic interpersonal therapy (PIT) in patients with multisomatoform disorder has been recently shown to improve health-related quality of life. To assess cost-effectiveness of PIT compared to enhanced medical care in patients with multisomatoform disorder. An economic evaluation alongside a randomised controlled trial (International Standard Randomised Controlled Trial Number ISRCTN23215121) conducted in 6 German academic outpatient centres was performed. Incremental cost-effectiveness ratio (ICER) was calculated from the statutory health insurance perspective on the basis of quality adjusted life years (QALYs) gained at 12 months. Uncertainty surrounding the cost-effectiveness of PIT was presented by means of a cost-effectiveness acceptability curve. Based on the complete-case analysis ICER was 41840 Euro per QALY. The results did not change greatly with the use of multiple imputation (ICER = 44222) and last observation carried forward (LOCF) approach to missing data (ICER = 46663). The probability of PIT being cost-effective exceeded 50% for thresholds of willingness to pay over 35 thousand Euros per QALY. Cost-effectiveness of PIT is highly uncertain for thresholds of willingness to pay under 35 thousand Euros per QALY.
Medical subject headings
- Outcome Assessment, Health Care
- Outpatients
- Psychotherapy, Brief
- Somatoform Disorders